EPISODE · Nov 25, 2019 · 10 MIN
Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Biostage, Inc. (BSTG)(“the Company”), a bioengineering company that is developing next-generation esophageal implants. CEO of the Company, Jim McGorry, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed Biostage, Inc. (BSTG)(“the Company”), a bioengineering company that is developing next-generation esophageal implants. CEO of the Company, Jim McGorry, joined Stock Day host Everett Jolly. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Biostage, Inc. Discusses Potential Clinical Trials for Their Next-Generation Esophageal Implants
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m